GEV vs ORCL: Which Is the Better Buy?

Side-by-side comparison of GE Vernova Inc. and Oracle Corporation β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-07-25.
GE Vernova Inc. Β· Industrials
$1,014.75
-16.2% upside to fair value
Med Conviction Grade C+
VS
Oracle Corporation Β· Technology
$184.31
+14.0% upside to fair value
Grade C High Quality
QuantHub Verdict
ORCL has more upside to fair value (+14.0%). ORCL trades at a lower forward P/E (31.0x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric GEV ORCL
Current Price $1,014.75 $184.31
Fair Value Estimate $850.00 $210.13
Upside to Fair Value -16.2% +14.0%
Market Cap $270.3B $530.1B
Forward P/E 34.3x 31.0x
EV / EBITDA 25.6x 20.4x
Price / Sales 6.6x 7.9x
Price / FCF 22.0x -22.4x
Revenue Growth YoY +15.0% +20.6%
Gross Margin 21.3% 65.8%
Operating Margin 5.9% 30.8%
Return on Equity 30.0% 50.4%
Dividend Yield 0.17% 0%
FCF Yield 4.5% β€”
Analyst Consensus Buy Strong Buy
Investment Thesis
GEV β€” GE Vernova Inc.
GE Vernova is the premier pure-play on the electricity side of the AI infrastructure supercycle. Its Power (heavy-duty gas turbines) and Electrification (grid equipment) segments are structurally supply-constrained, backed by a record $176B backlog that management says is 'mostly sold out through 2030.' The company raised FY2026 guidance for a second straight quarter to $45.5-46.5B revenue and $1…
ORCL β€” Oracle Corporation
Oracle Corporation is a leading enterprise software and cloud infrastructure provider with a durable competitive moat driven by its extensive software portfolio, strong cloud growth, and stable leadership. The company reported $57.4 billion in revenue for fiscal 2025, growing 8% year-over-year, with cloud services and license support growing 12%. Oracle's cloud infrastructure (OCI) is a key growt…
Accumulation Zones
Metric GEV ORCL
Zone Low $640.00 $157.60
Zone High $723.00 $178.61
In Buy Zone? No No
← GEV Research    ORCL Research β†’    All Research